SLS (Sodium Lauryl Sulfate): Should You Avoid It?

Is SLS bad? Search that phrase and the internet delivers a wall of warnings — cancer, hormone disruption, organ damage, a chemical so dangerous it doubles as an engine degreaser. Technically, water is also used as an engine degreaser. The evidence says something more specific and less dramatic. SLS is a well-documented skin and mucosal irritant. It is not a carcinogen, and it is not an endocrine disruptor. That distinction — irritant, not hormone disruptor — turns out to matter quite a lot for what you actually need to do about it.

Sodium lauryl sulfate is an anionic surfactantA molecule with a negatively charged head that dissolves in water and a hydrocarbon tail that grabs oils and grease — the basic mechanism behind all detergents and foaming cleaners. — a molecule with one end that grabs oils and grease and another that dissolves in water. First commercially developed in the 1930s, it remains the most widely used surfactant in personal care products because it is effective, cheap to produce, and creates the dense foam consumers associate with cleanliness.

The foam is cosmetic. It doesn't make the product clean better — cocamidopropyl betaineA milder amphoteric surfactant commonly used in SLS-free formulations, derived from coconut oil. Produces less foam but cleans equivalently. and other low-foam surfactants clean just as effectively. But consumer testing consistently shows people rate products with richer foam as more effective, even when cleaning performance is identical. SLS earns its place in formulations by meeting an expectation, not a functional requirement.

Where SLS gets into trouble is the same property that makes it work. A molecule designed to strip oil from a plate also strips oil from skin. At low percentages on the skin and oral mucosaThe mucous membrane — the moist tissue lining the inside of your mouth, nose, and other body cavities. Thinner and more permeable than outer skin., SLS denatures the protective proteins on tissue surfaces and disorders the lipid layer that holds moisture in Agner & Serup 1990. The effects are local, concentration-dependent, and reversible once exposure stops. That makes SLS an irritant — not a toxicant, not a typical allergen, not a systemic hazard.

SLS is in most things that foam. The concentration varies enormously — from under 1% in some toothpastes to 25% in certain shampoos — and the concentration determines whether you will notice any irritation.

The table explains why mouth ulcers are the best-documented effect. Toothpaste has the lowest SLS concentration but contacts your most sensitive tissue — oral mucosa — twice a day, every day. Shampoo has the highest concentration but sits on your scalp for a minute and gets rinsed off. The product with the lowest dose causes the most documented harm because it hits the most vulnerable surface. Concentration is half the story. Contact time and tissue type are the other half.

The other group that pays for daily SLS exposure is anyone whose hands stay in soapy water for a living. Hand eczema affects roughly 14.5% of adults at some point in their lives according to the largest meta-analysis on the question — 66 studies, 568,100 people Quaade et al. 2021. In Swedish hairdressers, a long-running occupational cohort recorded an incidence of 23.8 cases per 1,000 person-years, with hairdressers under 25 hitting 37.1 per 1,000 — about two and a half times the rate in the general population Lind et al. 2007. SLS is one of several surfactants involved in those formulations and isn't the only variable, but the pattern is consistent: skin that meets foaming detergent every day, several times a day, gets a documented price tag.

The clearest evidence concerns mouth ulcers. In 1996, Herlofson and Barkvoll ran a crossover trial on patients with recurrent aphthous stomatitisChronic mouth ulcers — painful, non-contagious sores on the oral mucosa that affect 5-25% of the general population. Often triggered by stress, trauma, or irritants like SLS. — chronic canker sores, the kind that return every few weeks regardless of what you eat. Two toothpastes: one containing SLS, one without. Same patients, both products, in random order, three months each. With the SLS-containing toothpaste, the group averaged 14.3 ulcers over three months. Without SLS: 5.1 Herlofson & Barkvoll 1996.

Twenty-five years of follow-up research confirmed the pattern. A 2019 systematic review pooled four crossover trials — 124 patients in total — and found that SLS-free toothpaste significantly reduced ulcer count, duration, episodes, and pain across every trial Alli et al. 2019. Recurrent aphthous stomatitis affects up to one in four people. If you are one of them, switching toothpaste is among the most straightforward evidence-based interventions in consumer health.

The mechanism in the mouth is dose-dependent. A 2023 review summarising the SLS oral-health literature notes that very low SLS concentrations — below about 0.015% — actually stimulate epithelial cell growth, while higher concentrations degrade cells and denature the mucinThe protective glycoprotein layer coating oral mucosa. Mechanically and chemically shields the tissue underneath from physical trauma and irritants. that protects oral tissue from mechanical and chemical irritation Sabri et al. 2023. The 0.5-2% SLS in commercial toothpaste sits well above the threshold where the molecule shifts from supportive to corrosive on this tissue. The protective layer gets stripped. The tissue underneath is exposed. If you are prone to ulcers, the cycle repeats every time you brush.

Here's the part the internet gets wrong. Five major agencies — IARCInternational Agency for Research on Cancer, the NTPNational Toxicology Program, the EPAUnited States Environmental Protection Agency, California Proposition 65, and the EU — have all assessed or reviewed SLS and none classify it as carcinogenic. It is not classified as a mutagen, a reproductive toxicant, or an endocrine disruptor Bondi et al. 2015. No peer-reviewed study has ever demonstrated estrogenic or anti-androgenic activity from SLS. Five agencies, zero carcinogenicity findings — the internet found a reason to worry anyway.

Most of the fear traces to a name confusion. SLESSodium laureth sulfate — a chemically distinct surfactant produced by ethoxylation. Can contain trace 1,4-dioxane as a manufacturing contaminant. — sodium laureth sulfate — is a different molecule, made by ethoxylating lauryl alcohol. That manufacturing step can leave behind trace 1,4-dioxaneAn IARC Group 2B probable carcinogen. A byproduct of ethoxylation — the process used to make SLES but not SLS. Removable by vacuum stripping during manufacture., an IARC Group 2B probable carcinogen. SLS is not ethoxylated and does not carry this contamination risk. One letter apart in the name. Different chemistry. Different hazard profile. The cancer scare that follows SLS around belongs to a different molecule — and even there, the concern is the byproduct, not the surfactant.

The mouth-ulcer literature gets quoted because it has a clean clinical endpoint — counted ulcers, before and after. The skin literature is quieter and broader, and it explains why irritation shows up at all. The headline measurement is TEWLTransepidermal water loss — how quickly water evaporates through the skin per unit area. Rises when the skin's lipid barrier is damaged. The standard non-invasive measure of barrier function in dermatology research., transepidermal water loss — how fast water escapes through the skin per square metre. A healthy stratum corneum holds water in. A damaged one leaks. TEWL goes up when the lipid barrier is compromised, and SLS is the chemical dermatologists most commonly use to compromise it on purpose, because it does so reliably.

More SLS produces more disruption every step of the way — there is no threshold below which the molecule does nothing. A 1990 dose-response study applied SLS to forearm patches at four concentrations — 0.25%, 0.5%, 1%, and 2% — and tracked the response with four bioengineering measurements: TEWL, blood flow, ultrasound-measured skin thickness, and visual scoring. All four parameters rose monotonically with concentration Agner & Serup 1990. Like adjusting the volume on a stereo, the curve does not snap on at some safe-to-unsafe threshold. It climbs.

The slower study is the more revealing one. A 2006 trial recruited twenty volunteers and exposed forearm skin to a 0.1% SLS solution every day for three weeks. 0.1% of SLS — the concentration in a single application is roughly a thousand times more dilute than what's in your shampoo is a vanishingly small dose. Each day, separately, would barely register. What the team measured was not single-day damage. They tracked stratum corneum cytokines — the small signalling proteins skin uses to coordinate inflammation and repair — and watched what accumulated.

By day twenty-one, IL-1α had dropped by about 30%. IL-1RA, a receptor antagonist, had risen tenfold. IL-8, a recruitment signal for immune cells, had risen fourfold de Jongh et al. 2006. Single exposures cleared up; cumulative exposure left a chemical fingerprint, the way a hand leaves an oil mark on a wall after enough touches. The barrier wasn't just being damaged. It was being briefed. The repair machinery had learned the chemical was coming.

The practical implication is what divides high-exposure populations from everyone else. A single shower with SLS shampoo does not produce measurable persistent effect in healthy skin. Two showers a day for ten years on hands that are also washing dishes, washing children, and washing clients' hair is what the cytokine pattern starts predicting. People with intact barriers and average exposure don't need to think about SLS on their skin. People with atopic dermatitisEczema — a chronic inflammatory skin condition affecting roughly 10% of adults. Skin barrier is genetically thinner and more permeable, making the wearer more reactive to surfactants and irritants. or jobs that wet their hands constantly are operating on a different curve.

Pharmacologists have a different name for what SLS does to skin. They call it a penetration enhancer. The same property that makes SLS an irritant — disordering the lipid bilayers between corneocytes, swelling the corneocytes themselves, denaturing surface proteins — is exactly the property that makes a transdermal drug formulation work. In the canonical review of the field, Williams and Barry list SLS alongside Azone, terpenes, and fatty acids as one of the workhorse molecules for getting drugs across skin Williams & Barry 2004. Used deliberately, the effect is measured in orders of magnitude — the flux of a co-applied drug can rise by a factor of ten or more.

Personal care formulations are not transdermal patches. The doses are smaller, the contact times are shorter, and rinsing helps. But the mechanism does not switch off because the use case is different. If a shampoo contains SLS at 12% plus a fragrance, plus a preservative, plus a few dyes, the SLS is doing partial work on the same skin those other molecules will be sitting on. The amount that crosses is small. It is not zero, and it is higher than it would be if the same fragrance, preservative, and dye were carried by a milder surfactant.

This is the brand-strategically interesting part of the SLS story. The cocktail effectThe combined biological impact of multiple chemicals in a single formulation, often greater than predicted from each chemical's individual hazard. Studied across endocrine disruptors but also relevant to penetration-enhanced absorption. is normally discussed in the context of endocrine disruptors — phthalates and parabens combining to do more than either alone. SLS doesn't disrupt hormones, but it sits inside formulations that may. The molecule isn't the headline concern in your shampoo. It might still be the courier for the rest of the bottle.

SLS is permitted in cosmetics and personal care products in every major jurisdiction without specific concentration limits for rinse-off products. The CIRCosmetic Ingredient Review — the US expert panel that assesses cosmetic ingredient safety assessed SLS in 1983: safe in formulations designed for brief use followed by rinsing, and safe in leave-on products at concentrations not exceeding 1% CIR 1983. Animal testing in the same report showed slight-to-moderate skin irritation at 0.5-10% SLS in occlusion patch testing, with corrosion at 10-30%. Above the leave-on ceiling, contact time and concentration determine whether a formulation produces irritation in real use.

The EU has not restricted SLS. It does not appear in Annex II (prohibited substances) or Annex III (restricted substances) of Cosmetics Regulation 1223/2009. The SCCSScientific Committee on Consumer Safety — the EU body that evaluates cosmetic ingredient safety has not issued a specific adverse opinion on it. The UK retained the EU position after Brexit with no divergence. In the US, SLS has a second regulatory life as a food additive under 21 CFR 172.822US federal regulation governing direct food additives. SLS is permitted as an emulsifier, whipping agent, and surfactant in specific food applications. — permitted as an emulsifier in egg whites at up to 1,000 ppm in solids, as a whipping agent in marshmallow gelatin at up to 0.5% by weight, and at lower concentrations in fumaric-acidulated beverage bases and oil-fat partition systems.

The regulatory stories worth reading involve SLES, not SLS. 1,4-dioxane — the byproduct that can survive ethoxylation if a manufacturer doesn't take it out — has been classified as Group 2B (possibly carcinogenic to humans) by IARC since 1999 (Monograph Volume 71). California listed it under Proposition 65 as a carcinogen in the late 1980s. In the EU, 1,4-dioxane is in Annex II of Cosmetics Regulation 1223/2009 — formally prohibited in cosmetic products — with an SCCS-derived trace tolerance of ≤10 ppmthe upper limit for unintended trace contamination of finished cosmetic products in the EU for unintended contamination.

New York moved further. Chapter 613 of the Laws of 2019 — bill S4389B, signed in December that year — added Section 37-0115 to New York Environmental Conservation Law. The limits stagger by product category: household cleansing products and personal care products at 2 ppm from 31 December 2022, tightening to 1 ppmthe New York State limit on 1,4-dioxane in household cleansers and personal care products since 31 December 2023 from 31 December 2023; cosmetic products held at 10 ppm from 31 December 2022. One part per million is roughly one second in eleven and a half days — the kind of concentration manufacturers can hit if they want to and ignore if regulators don't make them. NY DEC enforces. This is the strictest 1,4-dioxane regime in the United States.

What survives all this is solvable. Vacuum strippingA manufacturing step that exposes the surfactant to vacuum at controlled temperature, evaporating volatile contaminants like 1,4-dioxane. Standard practice for compliant SLES production but not universal. — exposing SLES to vacuum at controlled temperature so volatile contaminants evaporate — reduces 1,4-dioxane to single-digit parts per million or below. Manufacturers who do it can sell into New York and the EU. Manufacturers who don't, can't. The label on a product made with vacuum-stripped SLES looks identical to one made without — which is why this is a regulatory story, not a label story.

That depends on whether SLS is actually bothering you. Unlike the endocrine disruptors elsewhere in this library — chemicals where the evidence supports broad avoidance — SLS evidence supports targeted avoidance in specific scenarios.

If none of those apply, SLS in rinse-off products has been assessed as safe by every regulatory body that has looked at it. The energy you would spend avoiding SLS in shampoo is better directed at the chemicals that actually disrupt your hormones — the ones with evidence of systemic effects, not local irritation.

For SLS-free alternatives, three families show up most often. Sodium cocoyl isethionateA gentle coconut-derived surfactant popular in solid shampoo bars and facial cleansers — well-tolerated and effective, though produces less foam. is common in solid shampoo bars and facial cleansers. Cocamidopropyl betaine handles most liquid SLS-free formulations and pairs well with milder secondary surfactants. Decyl glucosideA non-ionic surfactant derived from corn glucose and coconut fatty alcohols. Mild, biodegradable, well-tolerated — common in baby and sensitive-skin formulations. and lauryl glucoside cover the sugar-derived side of the alternatives market. All three clean effectively. None foam quite as aggressively as SLS — which changes the sensory experience without changing the result.

One alternative does deserve a closer look. Sodium coco-sulfateA surfactant derived from coconut oil that is mostly sodium lauryl sulfate with smaller amounts of other chain lengths from coconut fatty alcohol. Marketed as a 'natural' alternative; chemically near-identical to SLS. is sometimes marketed as the gentler natural cousin to SLS. Chemically, it's mostly SLS with a few other chain lengths in the mix, derived from whole coconut oil rather than purified lauryl alcohol. The marketing is more different than the molecule. If your reason for switching from SLS is irritation, sodium coco-sulfate is unlikely to solve it.

The foam in your dish soap, your shampoo, and your toothpaste is doing what it was designed to do — and not much else. SLS strips oil from surfaces. When that surface is your oral mucosa, some people pay for it in canker sores. When it is your hands at a sink for twenty seconds, most people don't. When those same hands are at a salon basin for eight hours a day, the cytokine work catches up.

The evidence here is unusually clear for a chemical that generates so much anxiety online. SLS is an irritant, not a toxicant. If it is irritating you — mouth ulcers, dry scalp, reactive skin, occupational hand eczema — the fix is a formulation swap, not a lifestyle overhaul. If it is not, the ingredient list on your shampoo has more interesting reading further down. Start with the word 'fragrance.'